Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: John Posatiere who wrote (759)	12/22/1997 11:24:00 AM
From: Cisco	Read Replies (1) \| Respond to of 1894

John, Thanks, 1998 looking better all the time. BTW, they are predicting a chance of snow flurries for Christmas Day. Has it ever snowed there? When you see this stock headed toward double digits you may want to warn the authorities to expect a rowdy group from SI!<g> Cisco

To: John Posatiere who wrote (759)	12/22/1997 12:45:00 PM
From: Frank Buck	Read Replies (2) \| Respond to of 1894

John Posatiere, The decision of the University HealthSystem Consortium (UHC), (a national alliance of over 100 university-based health centers and associate hospitals to offer to their memebers the AcCell System says a lot. Here is a very key point/points. Charles Bartels, Director of Purchasing for UHC, indicated that the decision was made after considerable study of the marketplace. "We have been monitoring the emerging technologies in cytopathology for some time, and we have chosen the AcCell system because it is the only one on the market that addresses the entire screening process. This comprehensive approach can result in reduced operational costs and improved quality, which can translate into the ability for our members to be more competitive in their respective marketplaces,"he said. Should result in some significant sales down the pike when word catches on amongst the facilities. More reasons to add to the growing expectation that the revenue growth will continue for AccuMed. AccuMed's discounting to this group indicates a desire to get their system into the doors of such facilities so as to allow the market to determine the merits of the system. Frank